Jonathan Krinsky, BTIG chief market technician, joins 'Money Movers' to discuss his bullish call for this small sector to ...

On June 4, analysts at BTIG reiterated a Buy rating and maintained a $210 price target on Chart Industries Inc. (NYSE:GTLS).

BTIG analysts raised the price target for Liquidia Corporation (NASDAQ:LQDA) from $37 to $45 and kept a “Buy” rating. This ...

Russell 2000 nears breakout after a 7-month downtrend. Discover key sector inflection points & 5 small-cap stocks poised for ...

Shake Shack (SHAK) stock drops after BTIG downgrades to Neutral, citing concerns over guest frequency and valuation.

Alcon Inc. (NYSE:ALC) intends to expand its eye drop product sales team in order to support the launch of TRYPTYR. However, ...

The company anticipates a $139.8 million contingency liability and nearly $60 million related expense in a court battle with ...

Analysts awaiting specifics on the "implicit guarantee" for Fannie Mae and Freddie Mac are split on whether mortgage rates ...

Recent BTIG analyses reveal Airbnb’s performance is slowing this quarter compared to Booking and Expedia, whose numbers look ...

The Irving-based AI diagnostic company filed an S-1 registration statement to float Class A stock, and plans to list on the ...

The S&P 500 remained up nearly 2% heading into the final hour of trading Tuesday, as U.S. investors returned from a three-day holiday weekend and digested President Donald Trump's announcement he woul ...

On Thursday, BTIG analysts initiated coverage on Climb Bio (NASDAQ: CLYM) with a Buy rating and a price target of $7.00.Currently trading at $1.21, the stock sits well below its 52-week high of $9.58.